Too many beta-blockers

Abstract

Fifteen beta-blockers are marketed in the UK for systemic use. For their main indications alone - the treatment of hypertension and angina pectoris - over 70 differently named generic and proprietary products exist, often in several formulations, some combined with a diuretic or calcium antagonist. In this article, we discuss the use of beta-blockers generally and consider which are required to meet clinical needs.